NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Department of Health and Human Services
The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants applying for funding under this NOFO should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB) approvals, and establishment of drug (and placebo, if applicable) supplies, and any necessary third-party agreements should be established by the time of award. If time and support for these and other pre-
Funding
Award size
$1M – $10M
Award ceiling
1515000
Type
Grant
Dates
Deadline
Later
Posted
12/05/2024
Closes
2027-01-07
Eligibility
Eligibility
Special district governmentsCity or township governmentsPublic housing authorities/Indian housing authoritiesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Public and State controlled institutions of higher educationPrivate institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationState governmentsNative American tribal governments (Federally recognized)County governmentsFor profit organizations other than small businessesSmall businessesIndependent school districts
Program
Funding area
Health - HL
Opportunity #
PAR-25-025
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov